ArticleFrontiers in public health2025
Spatial networks of China's specialized, refined, distinctive, and innovative medical device firms based on parent-subsidiary contacts: implications for regional health policy.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Targeted proteoform degradation for precision drug design, delivery, and therapy.Drug delivery · 2026Review
- Clinical risk-aware reinforcement learning for latency-constrained healthcare IoT scheduling.Scientific reports · 2026Article
- Interpretable CRAM‑Enhanced Lightweight Dual‑Branch CNN for Real‑Time Breast Cancer Histopathology in Internet‑of‑Medical‑Things Environments.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Applications of artificial intelligence in mechanical engineering for the field of upper limb exoskeletons.Scientific reports · 2026Article
- Preliminary modeling of brain metastases in breast cancer: a neural network approach to risk factor analysis.BMC cancer · 2026Article
- A hybrid XGBoost-SVM ensemble framework for robust cyber-attack detection in the internet of medical things (IoMT).Scientific reports · 2026Article
- Federated Learning in Healthcare Ethics: A Systematic Review of Privacy-Preserving and Equitable Medical AI.Healthcare (Basel, Switzerland) · 2026Review
- Pollution transfer and environmental health implications: network evolution and proximity mechanisms in the Yangtze River Delta, China.Frontiers in public health · 2026Article
- Reframing workplace safety, wellbeing, and performance among operating room nurses in contemporary healthcare systems.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study examines the spatial structure and determinants of China's specialized, refined, distinctive, and innovative (SRDI) medical device industry through parent-subsidiary linkages. By combining social network analysis and geographical detectors, we analyze nationwide firm-level data from Qixinbao to explore network connectivity, centrality, and their socioeconomic drivers. The results show that (1) the overall network connectivity among Chinese cities is weak, with clear east-west disparities and Shanghai, Guangzhou, Beijing, and Shenzhen functioning as core hubs; (2) four distinct network subgroups exist, each assuming different roles in information and resource diffusion; and (3) factors such as economic base, degree of openness, and technological innovation are strongly associated with variations in network centrality across cities. These findings highlight the uneven spatial organization of China's SRDI medical device industry and underline the importance of strengthening interregional linkages, supporting innovation ecosystems, and improving talent and trade openness in less-developed regions. The study contributes to the literature by combining network analysis with spatial heterogeneity detection, offering empirical evidence for more balanced regional health industry development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.